$TERN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Terns Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Terns Pharmaceuticals, Inc.. Get notifications about new insider transactions in Terns Pharmaceuticals, Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 26 2021 | TERN | Terns Pharmaceutic ... | GORDON CARL L | Director | Option Exercise | A | 22.06 | 25,000 | 551,500 | 25,000 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 918,295 | 0 | 0 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 612,196 | 0 | 0 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 1,071,428 | 0 | 0 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 714,285 | 0 | 0 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | GORDON CARL L | Director | Buy | P | 17.00 | 285,000 | 4,845,000 | 2,274,723 | 2 M to 2.3 M (+14.32 %) |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | GORDON CARL L | Director | Buy | P | 17.00 | 190,000 | 3,230,000 | 1,516,481 | 1.3 M to 1.5 M (+14.32 %) |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | GORDON CARL L | Director | Buy | C | 0.00 | 1,989,723 | 0 | 1,989,723 | 0 to 2 M |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | GORDON CARL L | Director | Buy | C | 0.00 | 1,326,481 | 0 | 1,326,481 | 0 to 1.3 M |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 918,295 | 0 | 0 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 612,196 | 0 | 0 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,071,428 | 0 | 0 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 714,285 | 0 | 0 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | ORBIMED ADVISORS LLC | Director | Buy | P | 17.00 | 285,000 | 4,845,000 | 2,274,723 | 2 M to 2.3 M (+14.32 %) |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | ORBIMED ADVISORS LLC | Director | Buy | P | 17.00 | 190,000 | 3,230,000 | 1,516,481 | 1.3 M to 1.5 M (+14.32 %) |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,989,723 | 0 | 1,989,723 | 0 to 2 M |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,326,481 | 0 | 1,326,481 | 0 to 1.3 M |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 50,282 | 0 | 0 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 364,138 | 0 | 0 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 98,484 | 0 | 0 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 713,203 | 0 | 0 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 17.00 | 357,353 | 6,075,001 | 357,353 | 0 to 357.4 K |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 17.00 | 14,275 | 242,675 | 281,223 | 266.9 K to 281.2 K (+5.35 %) |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 17.00 | 103,372 | 1,757,324 | 2,036,557 | 1.9 M to 2 M (+5.35 %) |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 266,948 | 0 | 266,948 | 0 to 266.9 K |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 1,933,185 | 0 | 1,933,185 | 0 to 1.9 M |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 1,717,033 | 0 | 0 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 17.00 | 665,000 | 11,305,000 | 2,382,033 | 1.7 M to 2.4 M (+38.73 %) |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 1,717,033 | 0 | 1,717,033 | 0 to 1.7 M |
Page: 1